Literature DB >> 3077110

Value of non-drug treatment and drug treatment in hypertension.

L J Beilin1.   

Abstract

The benefits of the treatment of hypertension currently consist of a substantially reduced incidence of premature stroke, left ventricular failure and malignant hypertension. The benefits for the individual are most clearcut in those who have already had severe or symptomatic hypertension. Older subjects who have a higher risk of stroke and heart failure also show more immediate benefits in terms of stroke and heart failure reduction. However, in the community as a whole, mild hypertensives account for over half the cardiovascular deaths attributable to high blood pressure. In such patients a more systematic approach to the use of non-pharmacological measures for both control of blood pressure and coronary heart disease, coupled where necessary with the judicious use of existing and new antihypertensive and lipid lowering drugs, offers the prospect for a new era of prevention in relation to hypertensive cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3077110     DOI: 10.2165/00003495-198800366-00003

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  38 in total

1.  Australian National Health and Medical Research Council dietary salt study in mild hypertension.

Authors:  J Chalmers; T Morgan; A Doyle; B Dickson; J Hopper; J Mathews; G Matthews; R Moulds; J Myers; C Nowson
Journal:  J Hypertens Suppl       Date:  1986-12

2.  Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg.

Authors: 
Journal:  JAMA       Date:  1970-08-17       Impact factor: 56.272

3.  Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg.

Authors: 
Journal:  JAMA       Date:  1967-12-11       Impact factor: 56.272

4.  Evidence for a direct effect of alcohol consumption on blood pressure in normotensive men. A randomized controlled trial.

Authors:  I B Puddey; L J Beilin; R Vandongen; I L Rouse; P Rogers
Journal:  Hypertension       Date:  1985 Sep-Oct       Impact factor: 10.190

5.  Controlled, randomised trial of the effect of dietary fat on blood pressure.

Authors:  P Puska; J M Iacono; A Nissinen; H J Korhonen; E Vartianinen; P Pietinen; R Dougherty; U Leino; M Mutanen; S Moisio; J Huttunen
Journal:  Lancet       Date:  1983-01-01       Impact factor: 79.321

Review 6.  The fifth Sir George Pickering memorial lecture. Epitaph to essential hypertension--a preventable disorder of known aetiology?

Authors:  L J Beilin
Journal:  J Hypertens       Date:  1988-02       Impact factor: 4.844

7.  Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study.

Authors:  J Wikstrand; I Warnold; G Olsson; J Tuomilehto; D Elmfeldt; G Berglund
Journal:  JAMA       Date:  1988-04-01       Impact factor: 56.272

8.  Antihypertensive therapy and lipids. Evidence, mechanisms, and implications.

Authors:  M H Weinberger
Journal:  Arch Intern Med       Date:  1985-06

9.  Nutritional therapy for high blood pressure. Final report of a four-year randomized controlled trial--the Hypertension Control Program.

Authors:  R Stamler; J Stamler; R Grimm; F C Gosch; P Elmer; A Dyer; R Berman; J Fishman; N Van Heel; J Civinelli
Journal:  JAMA       Date:  1987-03-20       Impact factor: 56.272

10.  Regular alcohol use raises blood pressure in treated hypertensive subjects. A randomised controlled trial.

Authors:  I B Puddey; L J Beilin; R Vandongen
Journal:  Lancet       Date:  1987-03-21       Impact factor: 79.321

View more
  1 in total

1.  Opportunities to improve the cost-effectiveness of treatment for hypertension.

Authors:  B N Prichard
Journal:  Pharmacoeconomics       Date:  1992-03       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.